HOME >> MEDICINE >> NEWS
Breast cancer survivors experience long-term heart disease risk from radiotherapy

Women who were treated with radiation for breast cancer during the 1980s may be at an increased risk for heart disease compared with the general population, according to a new study in the March 7 Journal of the National Cancer Institute. Despite this increased risk of heart disease, radiation therapy has been previously shown to improve the chances of surviving breast cancer.

Breast cancer patients treated with radiation therapy during the 1970s are thought to have an increased risk of cardiovascular disease, but those treatment procedures are now considered obsolete. However, studies on the association between more modern radiation therapies and cardiovascular disease in breast cancer survivors have been inconclusive.

Maartje Hooning, M.D., of the Netherlands Cancer Institute in Amsterdam, and colleagues compared radiation treatment options, looking for differences in heart disease incidence among 4,414 10-year survivors of breast cancer who were treated between 1970 and 1986. Approximately half of the patients were treated for breast cancer between 1970 and 1980 and half were treated after 1980.

After a median follow-up of 18 years, the researchers identified 942 cases of cardiovascular disease, heart failure being the most common (382 out of 942). The breast cancer patients had an increase in the risk of heart attack, angina (chest pain due to an oxygen shortage in the heart), and congestive heart failure, compared with the general female population. The incidence of angina seemed to increase over time.

The researchers found differences in cardiovascular disease incidence depending on the type of treatment. Overall, patients who received radiation therapy had a greater risk of cardiovascular disease compared with those who received only surgery. In fact, the women who received only surgical treatment had a lower risk of heart attack than the general female population.

To examine the effects of changes i
'"/>

Contact: Liz Savage
elizabeth.savage@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
6-Mar-2007


Page: 1 2 3

Related medicine news :

1. Breast MRI may help determine surgical management of women with newly diagnosed breast cancer
2. Breastfeeding duration rates for infants born in an inner-city WHO/UNICEF Baby-Friendly hospital
3. Breastfeeding and good fats help new moms fight depression
4. Breastfeeding reduces risk of breast cancer for women who delay childbirth
5. Breastfeeding overcomes a genetic tendency toward ear infections, scientists discover
6. Breast cancer treatment procedure gives women more options
7. Breast cancer drug receives FDA approval
8. Breast reconstruction not as safe for obese patients
9. Breast asymmetry surgery improves quality of life, self-esteem
10. Breast discomfort during hormone therapy may indicate increased risk for breast cancer
11. Breast cancer survivors change lifestyle after diagnosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... ... Salveo for life, a company that distributes an effervescent lime-flavored drink called ... part of its presence to expand its market reach. , Using a formula developed ... nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, whilst supporting ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats ... of its owner and founder. As Oat is recognized globally as one of the ... personally as he believes it is a move to sow the seed of good ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... Rosa, CA (PRWEB) , ... January 21, 2017 ... ... the opening of its new medical office in Petaluma, located at 167 Lynch ... casting room, access to SRO sports medicine and rehabilitation services and ...
(Date:1/21/2017)... ... January 21, 2017 , ... The ... Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ARMO BioSciences, Inc., a late-stage immuno-oncology ... Company,s lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) at ... Society of Clinical Oncology (ASCO), taking place January 19-21, ... "AM0010 induces the expansion of novel ... cells in the blood and tumors of our patients," ...
(Date:1/21/2017)... Research and Markets has announced the addition of the "Advanced ... End User - Forecast to 2025" report to their offering. ... The Global Advanced ... around 7.8% over the next decade to reach approximately $330.70 billion ... markets for Advanced Drug Delivery across all the given segments on ...
(Date:1/20/2017)... DUBLIN , Jan 20, 2017 ... Laboratory Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte ... Panel), By End-use, And Segment Forecasts, 2013 - 2024" report ... ... USD 198.5 billion by 2024 Introduction of innovative solutions ...
Breaking Medicine Technology:
Cached News: